These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy. Anderson JE; Gooley TA; Schoch G; Anasetti C; Bensinger WI; Clift RA; Hansen JA; Sanders JE; Storb R; Appelbaum FR Blood; 1997 Apr; 89(7):2578-85. PubMed ID: 9116305 [TBL] [Abstract][Full Text] [Related]
3. The incidence of secondary leukemias. Leone G; Mele L; Pulsoni A; Equitani F; Pagano L Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043 [TBL] [Abstract][Full Text] [Related]
4. Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy. Seiter K; Feldman EJ; Sreekantaiah C; Pozzuoli M; Weisberger J; Liu D; Papageorgio C; Weiss M; Kancherla R; Ahmed T Leukemia; 2001 Jun; 15(6):963-70. PubMed ID: 11417484 [TBL] [Abstract][Full Text] [Related]
5. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462 [TBL] [Abstract][Full Text] [Related]
6. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia? Larson RA Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252 [TBL] [Abstract][Full Text] [Related]
7. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients. Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ; Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269 [TBL] [Abstract][Full Text] [Related]
8. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans. Larson RA; Le Beau MM Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816 [TBL] [Abstract][Full Text] [Related]
9. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results]. Haase D; Hanf V; Schulz T Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180 [TBL] [Abstract][Full Text] [Related]
10. Stem cell transplantation for leukemias following myelodysplastic syndromes or secondary to cytotoxic therapy. de Witte T; Oosterveld M; Span B; Muus P; Schattenberg A Rev Clin Exp Hematol; 2002 Mar; 6(1):72-85; discussion 86-7. PubMed ID: 12060485 [TBL] [Abstract][Full Text] [Related]
11. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650 [TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer. Roman-Unfer S; Bitran JD; Hanauer S; Johnson L; Rita D; Booth C; Chen K Bone Marrow Transplant; 1995 Jul; 16(1):163-8. PubMed ID: 7581117 [TBL] [Abstract][Full Text] [Related]
14. Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials. Pagano L; Pulsoni A; Vignetti M; Tosti ME; Falcucci P; Fazi P; Fianchi L; Levis A; Bosi A; Angelucci E; Bregni M; Gabbas A; Peta A; Coser P; Ricciuti F; Morselli M; Caira M; Foà R; Amadori S; Mandelli F; Leone G; Ann Oncol; 2005 Feb; 16(2):228-33. PubMed ID: 15668275 [TBL] [Abstract][Full Text] [Related]
15. First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia. Clavio M; Gatto S; Beltrami G; Cerri R; Carrara P; Pierri I; Canepa L; Miglino M; Balleari E; Masoudi B; Damasio E; Ghio R; Sessarego M; Gobbi M Leuk Lymphoma; 2001 Jan; 40(3-4):305-13. PubMed ID: 11426552 [TBL] [Abstract][Full Text] [Related]
16. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study. Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254 [TBL] [Abstract][Full Text] [Related]
17. Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias. Venugopal P; Manson S; Preisler HD Cancer Treat Res; 2001; 108():257-65. PubMed ID: 11702603 [No Abstract] [Full Text] [Related]
18. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. Löwenberg B; Suciu S; Archimbaud E; Haak H; Stryckmans P; de Cataldo R; Dekker AW; Berneman ZN; Thyss A; van der Lelie J; Sonneveld P; Visani G; Fillet G; Hayat M; Hagemeijer A; Solbu G; Zittoun R J Clin Oncol; 1998 Mar; 16(3):872-81. PubMed ID: 9508168 [TBL] [Abstract][Full Text] [Related]
20. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Smith SM; Le Beau MM; Huo D; Karrison T; Sobecks RM; Anastasi J; Vardiman JW; Rowley JD; Larson RA Blood; 2003 Jul; 102(1):43-52. PubMed ID: 12623843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]